[Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
D000070:Acebutolol / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000097:blood* / Q000494:pharmacology / Q000627:therapeutic use; D001798:Blood Proteins; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007019:Hypoproteinemia; D011433:Propranolol / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D011485:Protein Binding; D006435:Renal Dialysis; D014511:Uremia
D000319:Adrenergic beta-Antagonists; D001798:Blood Proteins; D000070:Acebutolol; D011433:Propranolol
Etude de la fixation des béta-bloquants aux protéines plasmatiques. Incidences thérapeutiques.